ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out of Dalhousie University, developing and manufacturing imageable embolic microspheres for interventional oncology. Its lead product, Eye90 microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable glass composition that is directly visible under fluoroscopy, X-ray and CT during and after the procedure, and it was granted FDA Breakthrough Device Designation for unresectable hepatocellular carcinoma and studied in the ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received FDA 510(k) clearance for embolization of hypervascular tumors and arteriovenous malformations. Devices are produced in the company's own cleanroom manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical is a regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no developer program, API documentation, SDK, or machine-readable API contract of any kind.
ABK Biomedical is profiled on the APIs.io network. Tagged areas include Medical Devices, Interventional Oncology, Radioembolization, Medical Imaging, and Oncology.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: abkbiomedical
name: ABK Biomedical
description: ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out of Dalhousie
University, developing and manufacturing imageable embolic microspheres for interventional oncology. Its lead product, Eye90
microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable glass composition that is directly
visible under fluoroscopy, X-ray and CT during and after the procedure, and it was granted FDA Breakthrough Device Designation
for unresectable hepatocellular carcinoma and studied in the ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received
FDA 510(k) clearance for embolization of hypervascular tumors and arteriovenous malformations. Devices are produced in the
company's own cleanroom manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical
is a regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no developer
program, API documentation, SDK, or machine-readable API contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/abkbiomedical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Medical Devices
- Interventional Oncology
- Radioembolization
- Medical Imaging
- Oncology
- Healthcare
- Manufacturing
- Canada
- Company
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://abkbiomedical.com/
- type: LinkedIn
url: https://ca.linkedin.com/company/abk-biomedical-inc-
- type: SecondaryMarket
url: https://equityzen.com/company/abkbiomedical
- type: DomainSecurity
url: security/abkbiomedical-domain-security.yml
x-tier: profiled
x-tier-reason: 'enrichment pass 2026-09-06: full STEP 0b contract discovery run against every known host, no public API surface
found'
x-enrichment:
date: '2026-09-06'
status: minimal
artifacts_added: 2
pass: local-v3
x-coverage:
state: none
reason: not-a-software-company
detail: 'ABK Biomedical manufactures implantable radioembolization and embolic microspheres (Eye90, Easi-Vue) in its own
Halifax cleanroom rather than software: no api., developer., dev., portal., app. or data. host exists in DNS, there is
no GitHub organization and no package under this name on npm or PyPI, and abkbiomedical.com is a SiteGround-hosted marketing
site whose every path — /robots.txt included — answers HTTP 202 with an sg-captcha interstitial rather than any document.'
evidence:
- url: https://abkbiomedical.com/.well-known/api-catalog
status: 202
- url: https://abkbiomedical.com/openapi.json
status: 202
- url: https://api.github.com/orgs/abkbiomedical
status: 404
- url: https://pypi.org/pypi/abkbiomedical/json
status: 404
- url: https://registry.npmjs.org/-/v1/search?text=abkbiomedical
status: 200
- url: https://equityzen.com/company/abkbiomedical
status: 200
checked: '2026-09-06'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.